Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2025-08-25 Interim / Quarterly Rep…
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "半年度报告摘要" which translates to "Half-Year Report Summary" for the year 2025. It contains detailed financial data such as total assets, net profit, revenue, and shareholder information for the half-year period. It also includes management assurances about the accuracy of the report and mentions that the report is unaudited. The content is comprehensive and includes substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. The document length is 5934 characters, which is sufficient to be the report itself rather than just an announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-25 Chinese
2025年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "宁波新芝生物科技股份有限公司 2025 年半年度报告" which translates to "Ningbo Scientz Biotechnology Co., Ltd. 2025 Semi-Annual Report." It contains detailed financial data such as revenue, profit, asset and liability figures, and operational details for the period January 1, 2025 to June 30, 2025. The document includes sections on accounting data, business overview, risk factors, and industry analysis. It explicitly states it is a "半年度报告" (half-year report) and includes comprehensive financial statements and management discussion. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-25 Chinese
第八届监事会第十九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Ningbo New Zhi Biotechnology Co., Ltd. It details the meeting date, attendance, and the approval of the company's 2025 semi-annual report and related special reports. The document references the actual 2025 semi-annual report and other reports published separately on the Beijing Stock Exchange information disclosure platform, indicating this document itself is not the report but an announcement of the meeting resolutions regarding those reports. The document length is short (1381 characters) and it does not contain the actual financial data or detailed report content, only the meeting decisions and voting results. Therefore, it fits best as a Regulatory Filing (RNS) since it is a formal announcement of supervisory board resolutions and references other filings but does not contain the reports themselves.
2025-08-25 Chinese
2025年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集资金存放、管理与实际使用情况的专项报告" which translates to a "Special Report on the Deposit, Management, and Actual Use of Raised Funds." It details the amount of funds raised, their usage, management, and balance as of June 30, 2025. It includes specific financial figures, project investment details, and compliance with regulatory approvals. The document is focused on the use and management of capital raised through a public stock issuance, including cash management and investment projects. This type of report is a detailed update on capital raising and usage, which fits the definition of a Capital/Financing Update (CAP). It is not an annual or interim report, nor an announcement of a report publication. It is not a regulatory filing or a general announcement but a substantive report on fundraising and capital usage.
2025-08-25 Chinese
会计估计变更公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting estimates related to depreciation methods and useful life of fixed assets. It includes details about the change, reasons, board and audit committee approvals, and the impact on financial statements. It does not contain full financial statements or comprehensive financial performance data. It is a regulatory announcement about an accounting policy change rather than a full report or financial statement. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (1653 characters), and it is not a report publication announcement but a substantive announcement of an accounting estimate change.
2025-08-12 Chinese
第八届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 21st meeting of the 8th Board of Directors of Ningbo New Zhisheng Biotechnology Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to governance-related proposals such as amendments to the company charter, establishment of board committees, and remuneration plans for directors and senior management. The document does not contain financial statements or earnings data but focuses on board decisions and governance matters. It is not a full annual or interim report, nor an earnings release or audit report. It is not a proxy solicitation or voting results announcement but rather a board meeting resolution announcement. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (7085 characters) and content confirm it is a substantive board meeting resolution announcement, not a brief notice or report publication announcement.
2025-08-12 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.